These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30808368)

  • 1. Economic burden of symptomatic iron deficiency - a survey among Swiss women.
    Blank PR; Tomonaga Y; Szucs TD; Schwenkglenks M
    BMC Womens Health; 2019 Feb; 19(1):39. PubMed ID: 30808368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of Trends in Anemia and Iron Deficiency in the Mexican Population From 1999 to 2018-19.
    De la Cruz-Góngora V; Villalpando S; Shamah-Levy T
    Food Nutr Bull; 2024 Mar; 45(1):57-64. PubMed ID: 38661355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Productivity losses due to influenza and influenza-like illness in Switzerland: results of the Swiss Sentinel Surveillance Network in a non-pandemic era.
    Tomonaga Y; Zens KD; Lang P; Born R; Schwenkglenks M;
    Swiss Med Wkly; 2021 Aug; 151(33-34):. PubMed ID: 34495605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of illness imposed by severe sepsis in Switzerland.
    Schmid A; Pugin J; Chevrolet JC; Marsch S; Ludwig S; Stocker R; Finnern H
    Swiss Med Wkly; 2004 Feb; 134(7-8):97-102. PubMed ID: 15106026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Erythrocyte Protoporphyrin a Better Single Screening Test for Iron Deficiency Compared to Hemoglobin or Mean Cell Volume in Children and Women?
    Mei Z; Flores-Ayala RC; Grummer-Strawn LM; Brittenham GM
    Nutrients; 2017 May; 9(6):. PubMed ID: 28561801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of Iron Deficiency Anemia in a Bariatric Surgery Population in the United States.
    Knight T; D'Sylva L; Moore B; Barish CF
    J Manag Care Spec Pharm; 2015 Oct; 21(10):946-54. PubMed ID: 26402393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic burden of depression in Sweden from 1997 to 2005.
    Sobocki P; Lekander I; Borgström F; Ström O; Runeson B
    Eur Psychiatry; 2007 Apr; 22(3):146-52. PubMed ID: 17194573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Iron substitution in outpatients in Switzerland: Increase of costs associated with intravenous administration].
    Giger M; Achermann R
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(4-5):320-6. PubMed ID: 23916272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland.
    Blach S; Schaetti C; Bruggmann P; Negro F; Razavi H
    Swiss Med Wkly; 2019 Mar; 149():w20026. PubMed ID: 30905063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of anaemia, deficiencies of iron and vitamin A and their determinants in rural women and young children: a cross-sectional study in Kalalé district of northern Benin.
    Alaofè H; Burney J; Naylor R; Taren D
    Public Health Nutr; 2017 May; 20(7):1203-1213. PubMed ID: 28120735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status.
    Comín-Colet J; Enjuanes C; González G; Torrens A; Cladellas M; Meroño O; Ribas N; Ruiz S; Gómez M; Verdú JM; Bruguera J
    Eur J Heart Fail; 2013 Oct; 15(10):1164-72. PubMed ID: 23703106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia, iron deficiency, and iron deficiency anemia in 12-36-mo-old children from low-income families.
    Schneider JM; Fujii ML; Lamp CL; Lönnerdal B; Dewey KG; Zidenberg-Cherr S
    Am J Clin Nutr; 2005 Dec; 82(6):1269-75. PubMed ID: 16332660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of overweight, obesity, and related complications in Switzerland 2021.
    Steinl D; Holzerny P; Ruckdäschel S; Fäh D; Pataky Z; Peterli R; Schultes B; Landolt S; Pollak T
    Front Public Health; 2024; 12():1335115. PubMed ID: 39071145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of iron deficiency diagnosis using hepcidin mass spectrometry dosage methods on hospital stay and costs after a prolonged ICU stay: Study protocol for a multicentre, randomised, single-blinded medico-economic trial.
    Lasocki S; Puy H; Mercier G; Lehmann S;
    Anaesth Crit Care Pain Med; 2017 Dec; 36(6):391-396. PubMed ID: 28919067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women.
    Fernández-Gaxiola AC; De-Regil LM
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009218. PubMed ID: 30699468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe.
    Péntek M; Gulácsi L; Brodszky V; Baji P; Boncz I; Pogány G; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Iskrov G; Schieppati A; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():89-98. PubMed ID: 27062257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of losartan in type 2 diabetics with nephropathy in Switzerland--an analysis of the RENAAL study.
    Szucs TD; Sandoz MS; Keusch GW
    Swiss Med Wkly; 2004 Aug; 134(31-32):440-7. PubMed ID: 15389347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.